Literature DB >> 2111123

Genes associated with rheumatoid arthritis and mild inflammatory arthritis. I. Major histocompatibility complex class I, II, and III allotypes.

A H Puttick1, D C Briggs, K I Welsh, R Vaughan, E A Williamson, M Boyce, R K Jacoby, V E Jones.   

Abstract

Patients with mild inflammatory arthritis (IA) were compared with patients with definite rheumatoid arthritis (RA) for abnormal frequencies of major histocompatibility complex (MHC) antigens and haplotypes to determine whether a genetic predisposition either to RA or to mild self-limiting arthritis/arthralgia was present in the patients with IA. In general the MHC antigens with abnormal frequencies found in patients with IA differed from those in patients with RA and were mainly at the A and B loci. In patients with IA the frequencies of HLA-A24, A25, B27, and B35 antigens were significantly higher than those of controls and HLA-DR5 and C4A4 were slightly raised. In contrast, in patients with RA abnormal frequencies of the MHC antigens DR4 and DR2 and the extended haplotypes associated with them [B62 BfS C4A3 C4B3 DR4 GLO2] and [B7 BfS C4A3 C4B1 DR2] confirmed the observations reported on other white populations. Thus MHC antigen associations with IA and RA differ sufficiently to suggest a different genetic basis for the two conditions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2111123      PMCID: PMC1004041          DOI: 10.1136/ard.49.4.219

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  23 in total

Review 1.  Are major histocompatibility system class III products independent markers for susceptibility to rheumatoid arthritis?

Authors:  P A Dyer; W Thomson; P A Sanders; D M Grennan
Journal:  Dis Markers       Date:  1986-06       Impact factor: 3.434

Review 2.  Seronegative rheumatoid arthritis and HLA-DR4: proposal for criteria.

Authors:  J T Gran; G Husby
Journal:  J Rheumatol       Date:  1987-12       Impact factor: 4.666

Review 3.  Molecular genetics of the HLA-D region component of inherited susceptibility to rheumatoid arthritis.

Authors:  J S Lanchbury
Journal:  Br J Rheumatol       Date:  1988-06

4.  A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10.

Authors:  J L Bidwell; E A Bidwell; D A Savage; D Middleton; P T Klouda; B A Bradley
Journal:  Transplantation       Date:  1988-03       Impact factor: 4.939

5.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

6.  Human parvovirus infection in early rheumatoid and inflammatory arthritis.

Authors:  B J Cohen; M M Buckley; J P Clewley; V E Jones; A H Puttick; R K Jacoby
Journal:  Ann Rheum Dis       Date:  1986-10       Impact factor: 19.103

7.  Immunoglobulin heavy chain switch region restriction fragment length polymorphisms are associated with renal disease.

Authors:  A G Demaine; D H Taube; R W Vaughan; L A Kerr; K I Welsh
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

8.  Genetic heterogeneity of rheumatoid arthritis.

Authors:  B M de Jongh; M L Westedt; R R de Vries; H A Valkenburg; A Cats
Journal:  Dis Markers       Date:  1986-06       Impact factor: 3.434

9.  HLA and rheumatoid arthritis: susceptibility or severity?

Authors:  D Jaraquemada; W Ollier; J Awad; A Young; H Festenstein
Journal:  Dis Markers       Date:  1986-06       Impact factor: 3.434

10.  Rheumatoid factor negative (seronegative) rheumatoid arthritis: evolving clinical classification and immunogenetic associations.

Authors:  A T Masi
Journal:  J Rheumatol       Date:  1988-01       Impact factor: 4.666

View more
  1 in total

1.  Genes associated with rheumatoid arthritis and mild inflammatory arthritis. II. Association of HLA with complement C3 and immunoglobulin Gm allotypes.

Authors:  A H Puttick; D C Briggs; K I Welsh; E A Williamson; R K Jacoby; V E Jones
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.